Literature DB >> 27648306

Gender-Based Differences and Barriers in Skin Protection Behaviors in Melanoma Survivors.

Jeffrey Chen1, Johnny Shih1, Andrew Tran1, Aaron Mullane1, Christina Thomas1, Nail Aydin2, Subhasis Misra2.   

Abstract

Purpose. Skin protection behaviors and environmental exposure play a crucial role in the development and subsequent management of melanoma. This study investigates gender-based differences in skin protection behaviors after melanoma treatment. Methods. Patients diagnosed and surgically treated for cutaneous melanomas over the last six years in a geographically high risk area were surveyed over telephone using a standardized script. Results. Of 150 survey results obtained, there were 82 males and 68 females. Overall, 87% of participants reported skin self-examination for abnormal markings more often and 94% reported wearing skin protective clothing more often, with females being more than males. Females limited outdoor activity more often than males, 79% to 54%, p < 0.05. When outside, females sought shade more often than males, 75% to 56%, p < 0.05. However, males wore a wide brim hat more often than females, 52% to 28%, p < 0.05. Interestingly, 60% of participants reported wearing SPF 30 sunscreen less often, p < 0.05. Conclusion. Larger percentage of females adopted behavioral changes to prevent future melanoma. Those living in high risk areas and with outdoor occupations need particular attention to skin care. Population based screening should be adopted to deal with this rising public health crisis.

Entities:  

Year:  2016        PMID: 27648306      PMCID: PMC5014947          DOI: 10.1155/2016/3874572

Source DB:  PubMed          Journal:  J Skin Cancer        ISSN: 2090-2913


1. Introduction

Skin cancer is considered the most common cancer in the United States. Melanoma is a malignancy of melanocytes, pigment-producing cells that reside in the basal epidermal layer. Melanoma accounts for less than 2% of skin cancers but accounts for most skin cancer related deaths [1]. The incidence of melanoma has been increasing for the past 30 years [2]. In 2015 alone, there were approximately 74,000 newly diagnosed cases, 5% of which were from Texas [1, 3]. The Texas Panhandle has one of the highest incidence rates in the state with 21.5 per 100,000 persons compared to the state average of 14.1 per 100,000 [4]. The Texas Panhandle also claims melanoma death rates nearly twice the national average [5, 6]. The national incidence and mortality of melanoma vary by gender, accounting for the 5th and 7th most common cancers in men and women, respectively [7]. In 2015, 67% of melanoma deaths occurred in men [1]. Risk factors that increase the risk of developing melanoma include “blue or green eyes, light colored skin, dysplastic nevi, abnormal moles, blistering sunburns, excessive UV exposure, psoralen therapy with UVA light, immunosuppression, and habitation closer to the equator or at higher elevations” [8-12]. Studies have also isolated six high risk factors that independently increase the risk of getting melanoma. They are “actinic keratosis, blond or red hair, family history of melanoma, upper back freckles, three or more blistering sunburns prior to age 20, and three or more years of outdoor occupation as a teenager” [13-15]. Individuals with one or two of the risk factors have a tripled risk of developing melanoma compared to the rest of the population, and patients with previous melanoma have a ninefold increase in risk of developing subsequent melanoma compared to the rest of the population [9, 16]. Thus, skin protection behaviors and environmental exposure play a crucial role in the development and subsequent management of melanoma. Recommendations to reduce the risks of melanoma deaths and recurrence include routine self-examinations for suspicious lesions, sun avoidance, use of sunscreen, and protective clothing [17]. However, not much research is available on skin protection behaviors after melanoma treatment, especially between genders. This study aims to investigate gender differences in skin protection behaviors after melanoma treatment.

2. Methods

We looked at a representative sample of cutaneous melanoma cases diagnosed and surgically treated in the Texas Panhandle, a geographically high risk area. All patients were treated by surgical oncologists between 2008 and 2015. Inclusion was limited to living patients of 18 years or older with biopsy-proven and surgically treated melanoma. Telephone surveys lasting 8 to 10 minutes were conducted using a standardized script with three main categories consisting of health maintenance, skin protection, and sun avoidance as follows. Telephone Survey Questions Section I: Health Maintenance How often in the past year have you visited any physician for a skin examination? How often in the past year have you had a full body skin check by a healthcare provider? How often in the past year have you self-examined your skin for abnormal markings (changing color, getting bigger, new mole) for growths? Section II: Skin Protection How often do you wear a hat with a wide brim all the way around? How often do you wear long sleeved shirts? How often do you wear sunscreen of at least SPF 30 How often do you wear sunglasses? How often do you wear pants that reach your ankles? Section III: Sun Avoidance Behavior How often do you limit your outdoor activity? When outside, how often do you seek shade? How often do you worry about developing another case of skin cancer? How often do you wear a hat, scarf, cap, or use an umbrella? The Last 2 Questions Have Different Answer Choices Surveys were mailed in prepaid envelopes to those who did not respond to at least three of our phone calls. Data was evaluated and p values were calculated for each of the survey questions. Since being diagnosed with melanoma, how often do you take part in outdoor activities compared to before the diagnosis? Significantly less, slightly less, the same, slightly more, significantly more Since being diagnosed with melanoma, how often do you worry about your melanoma compared to before the diagnosis? I worry a lot less, I worry slightly less, I worry about the same amount, I worry slightly more, I worry a lot more

3. Results

Responses were collected from 150 of 500 contacted participants, a 30% return rate. The participants included 82 males and 68 females with ages ranging from 18 to 88 years (Table 1). Overall, 87% of participants reported skin self-examination for abnormal markings more often, with females self-examining more often than men (Table 2). Of all participants, 94% reported wearing skin protective clothing (sunglasses, pants that reach the ankles, and long sleeved shirts) more often, with females being more than males. Females limited their participation in outdoor activities after their diagnosis of melanoma to a greater degree than males, 79% to 54%, p < 0.05. When outside, females sought shade more often than males, 75% to 56%, p < 0.05. Of all participants, 81% worried more about their melanoma compared to before their diagnosis with females worrying more than males, 90% to 73%, p < 0.05. On the contrary, males wore wide brim hats more often than females, 52% to 28%, p < 0.05. Interestingly, 60% of participants reported wearing SPF 30 sunscreen less often, with 67% of males and 52% of females wearing sunscreen less often than prior to their melanoma diagnosis, p < 0.05. We also looked at age, separating the patients into two age groups, over 55 and under 55, but results were not statically significant.
Table 1

Demographic characteristics.

Number%
Age
 Average59.4
 Range18–88
Gender
 Male 8255
 Female6845
Stage
 Stage 03825.3
 Stage 19160.7
 Stage 274.7
 Stage 342.7
 Stage 400
 Unstaged106.7
Table 2

Results showed that a larger percentage of females compared to males adopted behavioral changes to prevent future cutaneous melanoma, with the exception of the wide brim hat. A majority of both females and males used sunscreen of at least SPF 30 less often than prior to diagnosis.

Male (%)Female (%)
More often
 Wear wide brim hat5228
 Limit outdoor activity5479
 Seek shade5675
 Worry about recurrence7390
Less often
 Sunscreen SPF > 306752

4. Discussion

In 2013, the American Association for Cancer Research reported that between 1990 and 2009, melanoma death rates increased by 10.5% in men, while in the same period, melanoma death rates decreased by 9.6% in women [1, 3]. Over the past decade, studies have reported a gender disparity in the biology of melanoma, with males having an increased risk of having thicker (>2 mm) tumors, higher risk of progression, and higher risk of metastasis [18, 19]. Our study looked into what seems to be lacking in the literature, to see whether or not there is a gender-based difference in behavior after the treatment of melanoma. Results showed that a larger percentage of females compared to males adopted behavioral changes to prevent future cutaneous melanoma. Females were more likely to self-examine their skin for abnormal markings, and previous studies have shown a correlation between self- examinations and earlier melanoma diagnosis. Females were also more likely to wear protective clothing, limit their outdoor activity, and seek shade, which would ultimately lessen their exposure to UV radiation and decrease their risk of developing blistering sunburns, both of which are risk factors for melanoma. Women also worried more about their melanoma, which may be the underlying reason for their increased emphasis on preventative measures. One finding that seemed to deviate from the pattern was that men seem to wear a wide brim hat more often than females. This could possibly be due to behavioral change, but we hypothesize that it is more likely that males have careers involving agriculture or livestock in West Texas, so they are more likely to be outdoors for longer periods of time. Agriculture makes up the largest sector of the Texas Panhandle economy, and this predominately male workforce engaged in outdoor occupations including farming, ranching, and construction have a 6–8x higher UV exposure compared to workers in indoor occupations [20, 21]. Melanoma recurrence is higher than once thought, occurring in more than 6% of patients after 10 years, 6.8% of patients after 15 years, and 11.3% of patients after 25 years. Patients facing late recurrence were typically younger, with an average age of 41 to an average of 51 for early recurrence of melanoma [22, 23]. Studies have shown that sunscreen use decreases the incidence of sunburns. Sunburns, which can increase the likelihood of getting melanoma, are preventable, yet nearly 40% of the US population report getting sunburns each year [24, 25]. Thus, it is discouraging to find that more than half of the participants in both genders reported wearing sunscreen with greater than SPF30 less often than before their diagnosis of melanoma. We also looked at age to see if a certain age group was more or less likely to use sunscreen, but the data for two age groups, over 55 and under 55, was not statistically significant. The majority of respondents spent less time in outdoor activities after their diagnosis of melanoma. When asked about their sunscreen habits, the majority of those who spent less time outdoors believed that since they were outside for shorter periods of time, they no longer needed sunscreen. The second most popular response was that since sunscreen did not prevent melanoma in the first place, it probably was not going to prevent a recurrence. Our results point to the need of stronger patient education on the possibility of melanoma recurrence and on proper sunscreen usage to dispel misconceptions surrounding application efficacy. Due to its preventable nature and its increasing incidence, melanoma has been labeled a public health crisis by the US Surgeon General because a person who dies from melanoma has lost on average 20 years of potential life [1, 26, 27]. While there are no national guidelines in the United States regarding skin cancer screening, developed countries around the world, such as Belgium, Germany, Australia, France, and Japan have adopted population based screening for skin cancer. Germany has seen a nearly 40% decrease in melanoma mortality as a result [28, 29]. Patient adherence to preventative measures such as sunscreen needs to be pursued more aggressively. With 67% of melanoma deaths occurring in men and with less male attention to health maintenance, skin protection, and sun avoidance after melanoma treatment, more needs to be done in terms of education and follow-up, and mass population skin cancer screening should be adopted [1-3].
  17 in total

1.  Guidelines of care for primary cutaneous melanoma.

Authors:  A J Sober; T Y Chuang; M Duvic; E R Farmer; J M Grichnik; A C Halpern; V Ho; V Holloway; A F Hood; T M Johnson; B J Lowery
Journal:  J Am Acad Dermatol       Date:  2001-10       Impact factor: 11.527

2.  Systematic skin cancer screening in Northern Germany.

Authors:  Eckhard W Breitbart; Annika Waldmann; Sandra Nolte; Marcus Capellaro; Ruediger Greinert; Beate Volkmer; Alexander Katalinic
Journal:  J Am Acad Dermatol       Date:  2011-11-08       Impact factor: 11.527

3.  Preventing skin cancer among a farming population: implementing evidence-based interventions.

Authors:  Diana E Gaetano; Bernadette Hodge; Arleen Clark; Susan Ackerman; Patrick Burdick; Mary Lou Wranesh Cook
Journal:  AAOHN J       Date:  2009-01

4.  The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.

Authors:  Donatus U Ekwueme; Gery P Guy; Chunyu Li; Sun Hee Rim; Pratibha Parelkar; Suephy C Chen
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

Review 5.  Ultraviolet radiation and melanoma.

Authors:  Holly E Kanavy; Meg R Gerstenblith
Journal:  Semin Cutan Med Surg       Date:  2011-12

6.  Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.

Authors:  Alexander Katalinic; Annika Waldmann; Martin A Weinstock; Alan C Geller; Nora Eisemann; Ruediger Greinert; Beate Volkmer; Eckhard Breitbart
Journal:  Cancer       Date:  2012-04-19       Impact factor: 6.860

7.  Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis.

Authors:  Leslie K Dennis; Marta J Vanbeek; Laura E Beane Freeman; Brian J Smith; Deborah V Dawson; Julie A Coughlin
Journal:  Ann Epidemiol       Date:  2008-08       Impact factor: 3.797

Review 8.  The genome and epigenome of malignant melanoma.

Authors:  Christina Dahl; Per Guldberg
Journal:  APMIS       Date:  2007-10       Impact factor: 3.205

9.  Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE).

Authors:  J M Bliss; D Ford; A J Swerdlow; B K Armstrong; M Cristofolini; J M Elwood; A Green; E A Holly; T Mack; R M MacKie
Journal:  Int J Cancer       Date:  1995-08-09       Impact factor: 7.396

10.  Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030.

Authors:  Gery P Guy; Cheryll C Thomas; Trevor Thompson; Meg Watson; Greta M Massetti; Lisa C Richardson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-06-05       Impact factor: 17.586

View more
  12 in total

1.  The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017.

Authors:  Melissa R Laughter; Mayra B C Maymone; Chante Karimkhani; Chandler Rundle; Sophia Hu; Sophia Wolfe; Katrina Abuabara; Parker Hollingsworth; Gil S Weintraub; Cory A Dunnick; Adnan Kisa; Giovanni Damiani; Aziz Sheikh; Jasvinder A Singh; Takeshi Fukumoto; Rupak Desai; Ayman Grada; Irina Filip; Amir Radfar; Mohsen Naghavi; Robert P Dellavalle
Journal:  JAMA Dermatol       Date:  2020-08-01       Impact factor: 10.282

2.  A cancer registry-based analysis on the non-white populations reveals a critical role of the female sex in early-onset melanoma.

Authors:  Tze-An Yuan; Frank Meyskens; Feng Liu-Smith
Journal:  Cancer Causes Control       Date:  2018-03-09       Impact factor: 2.506

3.  Prevalence and correlates of skin self-examination behaviors among melanoma survivors: a systematic review.

Authors:  Trishnee Bhurosy; Carolyn J Heckman; Mary Riley
Journal:  Transl Behav Med       Date:  2020-10-12       Impact factor: 3.046

4.  Estimating policy-relevant health effects of ambient heat exposures using spatially contiguous reanalysis data.

Authors:  Temilayo E Adeyeye; Tabassum Z Insaf; Mohammad Z Al-Hamdan; Seema G Nayak; Neil Stuart; Stephen DiRienzo; William L Crosson
Journal:  Environ Health       Date:  2019-04-18       Impact factor: 5.984

5.  A Systematic Review of Immune Checkpoint Inhibitor-Associated Glomerular Disease.

Authors:  Abhijat Kitchlu; Kenar D Jhaveri; Shikha Wadhwani; Priya Deshpande; Ziv Harel; Teruko Kishibe; Kammi Henriksen; Rimda Wanchoo
Journal:  Kidney Int Rep       Date:  2020-10-16

6.  Comment on "Gender-Based Differences and Barriers in Skin Protection Behaviors in Melanoma Survivors".

Authors:  Vinayak K Nahar; Amanda K Hutcheson; Javier F Boyas; Stephanie K Jacks; Robert T Brodell
Journal:  J Skin Cancer       Date:  2016-11-16

7.  Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts.

Authors:  Abdullah Al Emran; Jérémie Nsengimana; Gaya Punnia-Moorthy; Ulf Schmitz; Stuart J Gallagher; Julia Newton-Bishop; Jessamy C Tiffen; Peter Hersey
Journal:  Cancers (Basel)       Date:  2020-07-28       Impact factor: 6.639

8.  Impact of Immediate Surgical Reconstruction Following Wide Local Excision of Malignant Head and Neck Melanoma.

Authors:  Allison C Hu; Seung Ah Lee; Emily G Clark; Maki Yamamoto; James G Jakowatz; Gregory R D Evans
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-02-24

9.  Feminism, gender medicine and beyond: a feminist analysis of "gender medicine".

Authors:  Ayelet Shai; Shahar Koffler; Yael Hashiloni-Dolev
Journal:  Int J Equity Health       Date:  2021-08-03

10.  Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial.

Authors:  Amelia K Smit; Martin Allen; Brooke Beswick; Phyllis Butow; Hugh Dawkins; Suzanne J Dobbinson; Kate L Dunlop; David Espinoza; Georgina Fenton; Peter A Kanetsky; Louise Keogh; Michael G Kimlin; Judy Kirk; Matthew H Law; Serigne Lo; Cynthia Low; Graham J Mann; Gillian Reyes-Marcelino; Rachael L Morton; Ainsley J Newson; Jacqueline Savard; Lyndal Trevena; Sarah Wordsworth; Anne E Cust
Journal:  Genet Med       Date:  2021-08-12       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.